Full-Life Technologies is a fully-integrated clinical-stage global radiotherapeutics company with operations in Belgium, Germany, and China. The company focuses on the research, development, production, and commercialization of radiopharmaceuticals, aiming to address key challenges in the field. Full-Life is committed to pioneering innovative solutions to enhance oncology treatments, particularly through Radionuclide Drug Conjugates (RDCs) and alpha emitter therapies, while establishing a comprehensive value chain to deliver significant clinical impact for patients.